electroCore (ECOR) Set to Announce Quarterly Earnings on Wednesday

electroCore (NASDAQ:ECORGet Free Report) is scheduled to be announcing its earnings results after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.50) per share for the quarter.

electroCore (NASDAQ:ECORGet Free Report) last announced its quarterly earnings results on Wednesday, March 13th. The company reported ($0.61) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.06). electroCore had a negative return on equity of 201.47% and a negative net margin of 117.49%. The business had revenue of $5.19 million during the quarter, compared to the consensus estimate of $5.23 million. During the same quarter in the prior year, the firm posted ($1.22) EPS. On average, analysts expect electroCore to post $-2 EPS for the current fiscal year and $0 EPS for the next fiscal year.

electroCore Stock Performance

ECOR stock traded up $0.11 during trading on Thursday, hitting $6.15. 103 shares of the company’s stock traded hands, compared to its average volume of 12,624. The business has a fifty day simple moving average of $6.24 and a 200 day simple moving average of $6.21. electroCore has a 52 week low of $3.83 and a 52 week high of $8.08. The stock has a market capitalization of $36.90 million, a price-to-earnings ratio of -1.70 and a beta of 0.91.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a “buy” rating on shares of electroCore in a research note on Thursday, March 14th.

Get Our Latest Stock Report on electroCore

electroCore Company Profile

(Get Free Report)

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.

Further Reading

Earnings History for electroCore (NASDAQ:ECOR)

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.